Top

Collaborations to Enhance Drug Development and Regulatory Science

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Food and Drug Administration, under the Department of Health and Human Services, is seeking applications for a cooperative agreement to support the Critical Path Initiative. This initiative focuses on managing Public-Private Partnerships and collaborative activities aimed at advancing regulatory science. The primary goal is to foster drug product innovation by accelerating development, supporting advanced manufacturing, translating basic science into therapeutics, and improving the overall safety, efficacy, and quality of drug products. The FDA will identify specific projects for research, education, and outreach, with multiple awards potentially granted based on drug development priorities and available funding. This opportunity is categorized under NAICS code 541715 and was posted on November 30, 2023. Interested parties can coordinate through the designated point of contact, Terrin Brown.

General Info

FDA seeks collaborative projects to accelerate drug development through regulatory science and public-private partnerships.

Agency

Department Of Health And Human Services → Food And Drug Administration

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedNov 30

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → Food And Drug Administration

Contacts1 person available

OfficeUSA

Organization / Agency

Department Of Health And Human Services → Food And Drug Administration

Office AddressUSA

Contacts

Terrin Brown Grantor

contact@example.gov

+1 (555) 000-0000

Full Description

This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA. Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.